Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicity
Molecular Biology Reports · 2024-12 · 51 (1)
DOI: 10.1007/s11033-024-09327-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 20.04.2024. Verfasst von Marco Cirronis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Edinburgh Clinical Toxicology, Royal Infirmary of Edinburgh, Edinburgh, UK. mcirronis@asst-pg23.it. Hauptthemen laut MEDLINE: Analgesics, Non-Narcotic, Chemical and Drug Induced Liver Injury, MicroRNAs, Chemical and Drug Induced Liver Injury, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Paracetamol (acetaminophen) overdose is a leading cause of acute liver failure in many Western countries. Diagnostic tools for this poisoning may be suboptimal in some cases and new biomarkers have been investigated. We investigated the role of capillary microRNA-122 (miR-122) as a prognostic biomarker of liver injury in the clinical management of patients with paracetamol overdose. METHODS: In a paracetamol overdose patient cohort, miR-122 was measured by quantitative polymerase chain reaction in a blood drop obtained by a finger prick at the end of an antidote cycle treatment with N-acetylcysteine treatment (12 h). Liver injury was defined as serum alanine aminotransferase (ALT) activity > 100 IU/L collected at 10 or 20 h after the start of treatment. Pearson's correlation analyses were performed. RESULTS: In patients with paracetamol overdose, capillary miR-122 was positively correlated with ALT measured at 10 h and at 20 h (r = 0.83, P < 0.0001; r = 0.96, P < 0.0001, respectively). CONCLUSION: This work supports the potential use of capillary miR-122 as a prognostic biomarker of liver injury throughout clinical management of patients with paracetamol overdose. Capillary miR-122 can be measured in a blood drop collected by a finger prick, a minimally invasive diagnostic test for patient stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Edinburgh Clinical Toxicology, Royal Infirmary of Edinburgh, Edinburgh, UK. mcirronis@asst-pg23.it.
- Department of Neuroscience, Psychiatry, Drug Area and Child Health (NEUROFARBA), Section of Pharmacology and Toxicology, University of Florence, Florence, Italy. mcirronis@asst-pg23.it.
- Bergamo Poison Control Center & Teratology Information Service, ASST Papa Giovanni XXXIII Hospital, Bergamo, Italy. mcirronis@asst-pg23.it.
- Edinburgh Clinical Toxicology, Royal Infirmary of Edinburgh, Edinburgh, UK.
- Julius Center for Health Sciences and Primary Care, Department of Medical Humanities, University Medical Center Utrecht, 3508 GA, Utrecht, Netherlands.
- Pharmacology, Toxicology and Therapeutics, University/BHF Centre for Cardiovascular Science, Edinburgh University, Edinburgh, UK.
Zitieren
APA
Cirronis, M., Schneemann, S., Pettie, J., Mannaioni, G., & Dear, J. W. (2024). Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicity. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09327-6
Vancouver
Cirronis M, Schneemann S, Pettie J, Mannaioni G, Dear JW. Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicity. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09327-6
BibTeX
@article{Cirronis2024,
author = {Cirronis, Marco and Schneemann, Sarah and Pettie, Janice and Mannaioni, Guido and Dear, James W},
title = {Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicity},
journal = {Molecular Biology Reports},
year = {2024},
volume = {51},
number = {1},
doi = {10.1007/s11033-024-09327-6}
}
EUVIMED